Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-17T01:33:26.143Z Has data issue: false hasContentIssue false

N1-methylnicotinamide excretion and affective disorders

Published online by Cambridge University Press:  09 July 2009

C. L. Cazzullo*
Affiliation:
Biological Psychiatry Research Unit, Department of Psychiatry, Milan University Medical School
E. Sacchetti
Affiliation:
Biological Psychiatry Research Unit, Department of Psychiatry, Milan University Medical School
E. Smeraldi
Affiliation:
Biological Psychiatry Research Unit, Department of Psychiatry, Milan University Medical School
*
1Address for correspondence: Dr C. L. Cazzullo, Biological Psychiatry Research Unit, Department of Psychiatry, Milan University Medical School, Via F. Sforza, 35–20122 Milan, Italy.

Synopsis

N1-Methylnicotinamide urinary output is examined in 38 healthy volunteers, 52 patients with secondary affective disorders (SAD), 55 patients with primary affective disorders (PAD) and 46 healthy first-degree relatives of PAD patients. The results indicate (1) that in PAD patients and their first-degree relatives the frequency of low Nl-MN excretion was significantly higher (p < 0001) than in healthy controls and in patients with secondary affective disorders, and (2) that PAD patients have a consistently low N1-MN output, at all times constant and independent of the clinical phases of the disease. These findings provide evidence that the low N1-MN levels may represent an index of a biological background linked to a high morbidity risk for primary affective disorders. The theoretical implications deriving from these data are briefly discussed.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1976

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable